Hyoscyamine Sulfate, Orally Disintegrating Tablets, 0.125 mg, 100-count bottles, Rx only, Manufactured for: Virtus Pharmaceuticals OPCO II, LLC., Nashville, TN 37217, NDC 76439-307-10.
Published December 28, 2016 · Recall initiated: September 2, 2016
Summary
FDA records drug Class I recall D-0213-2017, published December 28, 2016 and initiated September 2, 2016. Recalling firm: VIRTUS PHARMACEUTICALS OPCO II L; Status: Terminated; Reported quantity: 10,572 bottles; Lot: Lot #: 30011601, Exp 01/18. Class I means a reasonable probability of serious adverse health consequences or death.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Content Uniformity Specifications: resulting in both superpotent and subpotent tablets.
What to do
Voluntary: Firm initiated · E-Mail
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- VIRTUS PHARMACEUTICALS OPCO II L
- Distributor
- Nationwide and Puerto Rico
- Lot
- Lot #: 30011601, Exp 01/18
- Risk classification
- Class I
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAVirt-Select Prenatal/Postnatal Softgels, Prescription Multivitamin/Mineral Dietary Supplement with Fish-BasedJanuary 4, 2017
- FDAExtra-Virt Plus DHA Prenatal/Postnatal Softgel, Prescription Multivitamin/Mineral Dietary Supplement withJanuary 4, 2017
- FDAVirt-Advance Prenatal/Postnatal Softgels, Prescription Folic Acid Containing Dietary Supplement, packaged inJanuary 4, 2017
- FDAVirtPrex Prenatal/Postnatal Tablets, Prescription Supplement Containing Folic Acid and DHA, packaged inJanuary 4, 2017
- FDAHyoscyamine Sulfate, Sublingual Tablets, 0.125 mg, 100-count bottle, Rx only, Manufactured for: VirtusDecember 28, 2016
- FDALamotrigine Orally Disintegrating Tablets (ODT), 200 mg, 30 Tablets 3 blisters containing 10 tablets each, RxDecember 28, 2016
Questions about this recall
Was Hyoscyamine Sulfate, Orally Disintegrating Tablets, 0.125 mg, 100-count bottles, Rx only, Manufactured for: Virtus Pharmaceuticals OPCO II, LLC., Nashville, TN 37217, NDC 76439-307-10. recalled?
Yes. FDA published recall D-0213-2017 on December 28, 2016. Reported hazard: Failed Content Uniformity Specifications: resulting in both superpotent and subpotent tablets.
What should I do if I have this product?
Voluntary: Firm initiated · E-Mail